Purchase Order 70US0923P70092346

Award Date 8/1/23
Potential Completion Date 2/12/25
Potential Value $65K
Federal Agency
Secret Service
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Grand Prairie, TX 75052, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $124,659.50 firm fixed price delivery order was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7 to Seqirus USA Inc., a foreign-owned for-profit manufacturer, to provide FLUAD influenza vaccines for the 2020-2021 season. The contract was not set aside. Seqirus USA Inc. has previously supplied influenza vaccines to various federal agencies including the Department of Defense, Department of Justice Bureau of Prisons, and...
This federal contract award was issued by the Department of Health and Human Services (HHS) to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccines. The $940,522.50 firm fixed price purchase order is for the delivery of flu vaccines. Seqirus USA Inc. has previously received awards from other federal agencies, including the Department of Defense, Department of Veterans Affairs, Department of Justice Bureau of Prisons, and the Centers for Disease Control and...
The U.S. Department of Health and Human Services has awarded a $22,428.00 firm-fixed-price purchase order contract to Seqirus USA Inc., a global biotechnology company, for the delivery of flu vaccines during the 2024-2025 season. This award is not a set-aside contract. Seqirus, through its Seqirus Usa, Inc. division, is a major supplier of influenza vaccines to various federal agencies, including the Department of Defense, Department of Veterans Affairs, Department of Health and Human...
This is a firm-fixed-price delivery order awarded by the National Institutes of Health (NIH) to Seqirus USA Inc. through the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract, valued at $307,666.00, is for the delivery of influenza virus vaccines to the NIH Clinical Center. This award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at over $500 million that Seqirus holds with the Centers for Disease Control and Prevention (CDC) for...
This federal contract award is for the delivery of flu vaccines by Seqirus USA Inc., a global biotechnology company, to various U.S. government agencies including the Department of Defense, Department of Veterans Affairs, Department of Health and Human Services, and Department of Justice. The contract, valued at $1,351,500.00, is a Firm Fixed Price Purchase Order with a completion date of July 7, 2019. The contract is not designated as a set-aside. Seqirus USA Inc. has been awarded numerous...
This is a firm-fixed-price delivery order awarded by the Office of the Assistant Secretary for Administration, a civilian federal agency, to Seqirus USA Inc. for the supply of 2023-2024 influenza virus vaccines in pre-filled syringes. The contract, valued at $87,165.00, has an ultimate completion date of July 16, 2023 and was awarded on June 16, 2023. This order is placed under Seqirus's existing Indefinite Delivery Contract (IDC) with the Department of Veterans Affairs National Acquisition...
This $642,000.00 firm-fixed-price delivery order was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Seqirus USA Inc. through its Seqirus Usa, Inc. division. The order was placed under the Pandemic Influenza Preparedness and Response 2012-2016 Indefinite Delivery Contract, a multi-year vehicle managed by ASPR. The contract supports the delivery of influenza vaccines, which Seqirus specializes in manufacturing and supplying to various...
This federal contract award from the Department of Veterans Affairs (VA) Veterans Health Administration is for the delivery of flu vaccines to support the VA's immunization program. The $189,677.88 firm fixed price delivery order was issued to the prime contractor, Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccines. Seqirus USA Inc. has a history of providing influenza vaccines to various federal agencies, including the Department of Defense, Department of...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services to Seqirus USA Inc., a global biotechnology company, for the delivery of influenza vaccines. The contract, valued at $1,608,584.60, does not have a set-aside designation. Seqirus USA Inc. has a history of providing influenza vaccines to various federal government customers, including the Department of Defense, Department of Veterans Affairs, Department of Justice Bureau of Prisons, and the Department...
This federal contract award was made by the Federal Correctional Institution Maxwell (an agency within the Department of Justice) to Seqirus USA Inc. through its Seqirus Usa, Inc. division. The award, valued at $2,914.14, is for the delivery of AFLURIA TRIVALENT OR QUADRIVALENT MULTI-DOSE VIAL (10 DOSES/VIAL) X 30 and FLUAD TRIVALENT OR QUADRIVALENT PRE-FILLED SYRINGE (PFS) > 65 (10DOSES/BOX) X 2. This is a firm-fixed-price purchase order contract with an ultimate completion date of April 11,...

This federal contract award ID 70US0923P70092346 was issued by the U.S. Secret Service, a civilian agency, to Americanurse Staffing Agency, LLC, a minority-owned small business. The $64,581.00 firm fixed-price purchase order is for the annual supply of Fluzone vaccinations, with delivery to Washington, D.C. The contract has a base period from August 1, 2023 to July 31, 2024, with four one-year option periods. No set-aside was used for this procurement, which was conducted through a competitive reverse auction on the Unison Marketplace platform.

Generated 5/9/25, 9:44 AM